WallSt.net Updates Investment Community Through All-New Interview With Transplant...

WallSt.net Updates Investment Community Through All-New Interview With
Transplant Creations

NEW YORK, Jan. 16 /PRNewswire/ -- On January 10, Dr. Marlies Van Hoef, CEO
of Transplant Creations (http://www.transplantcreations.com) updated the
investment community in an all-new interview with www.wallst.net. Topics
covered in the interview include an overview of the company, recent press, the
market opportunity and upcoming milestones for which investors should watch.
To hear the interview in its entirety, visit the Company website at
http://www.transplantcreations.com or go to
http://www.wallst.net/audio/audio.asp?ticker=PRIVATE&id=4341.
About Transplant Creations:
Experienced in evaluation of the therapeutic potential of products,
Transplant Creations' service department provides advice in strategic planning
during the preclinical stage of development, during early or late stage
clinical development, or at a moment that companies consider acquisition or
development of a product in a therapeutic area within our focus.
Specialized in hematopoietic stem cell transplantation with a focus on
malignant diseases and a back-ground in oncology and hematology the Company
has developed a unique "delivery method" for "drug combinations", autologous
stem cell support and allogeneic hematopoietic stem cell grafting.
The investment sector has been focusing on drugs and technologies as
targets for investment, said Van Hoef, we focus on method development through
same clinical research principles as drug development.
Van Hoef emphasized that there is an opportunity for investment in methods
that has remained unexplored. The Company's unique method offers superior
perspectives for disease outcome.
The mission for 2008 and beyond is to invite investors and the public to
get involved in implementation of the method.
For more information, please visit http://www.transplantcreations.com.
About WallSt.net:
www.wallst.net is owned and operated by WallStreet Direct, Inc., a wholly
owned subsidiary of Financial Media Group, Inc. The Web site is a leading
provider of timely business news, executive interviews, multimedia content and
research tools. Financial Media Group, Inc. also owns http://www.mywallst.net,
a financial social network for investors, and Financial Filings Corp., a
provider of compliance solutions to publicly traded companies. Additionally,
WallStreet Direct, Inc. owns and operates WallStRadio, a business and finance
podcast Web site. Financial Filings Corp. is expecting to receive two hundred
eighty dollars from Transplant Creations for the dissemination of this press
release. For a complete list of our advertising relationships, visit
http://www.wallst.net/disclaimer/disclaimer.asp.
Contact: WallSt.net
800-4-WALLST

SOURCE WallStreet Direct, Inc.

WallSt.net, 1-800-4-WALLST